American Friends of Dental Volunteers for Israel (AFDVI), a 501(c)(3) non-profit organization, announced today a charity event featuring two of the stars of The Marvelous Mrs. Maisel. “Meet the Maisels: Behind the Scenes of The Marvelous Mrs. Maisel,” will be held at 7:30PM on Sunday, December 1, 2019 in the Septodont Lecture Hall of New York University’s College of Dentistry. Sponsored by Henry Schein, Inc., Septodont, I Fish Haines Alaska and Glacier View Lodge, Practice Perfect Systems, Drs. Douglas and Margo Woll and others, the event will benefit the Dental Volunteers for Israel (DVI) Trudi Birger Clinic in Jerusalem.
The DVI Clinic is the largest free dental clinic in Israel, offering state-of-the-art dental treatment to Jerusalem’s underserved and special needs children and at-risk youth, ages 4 to 26, and needy seniors, aged 65 and older, including Holocaust survivors,. Each year more than 100 volunteer dentists treat an average of 2,700 children and young adults and provide preliminary dental care to over 100 seniors receiving dentures.
Actors Michael Zegen (Joel Maisel) and Caroline Aaron (Joel’s mother Shirley Maisel) will share their experiences on the set of the Amazon Original Series which has won, among other awards, the 2018 Primetime Emmy for Outstanding Comedy Series and the 2018 Golden Globe for Best Television Series-Musical or Comedy. Mr. Zegen and Ms. Aaron won the 2019 Screen Actors Guild Award for Outstanding Performance by an Ensemble in a Comedy Series.
“In 1958 New York, Midge Maisel's life is on track - husband, kids, and elegant Yom Kippur dinners in their Upper West Side apartment. But when her life takes a surprise turn, she has to quickly decide what else she's good at - and going from housewife to stand-up comic is a wild choice to everyone but her.”
Ms. Sara Lee Kessler, Anchor at NBC News Radio and 77 WABC, will be the moderator for the evening.
“We are thrilled to be able to present such a fun and interesting program for friends from around the world who support our work with the DVI Clinic, and for the new friends we are likely to make as fans of the actors and the show,” said Dr. Scott Dubowsky, President of AFDVI and DVI Clinic volunteer. “I think we all secretly dream of being on the set of a television show or movie to see how everything comes together. We can’t wait to hear from Michael and Caroline what exactly that’s like.”
More information about the event and tickets: www.americanfriendsofdvi.org/maisel.
About American Friends of Dental Volunteers for Israel
The mission of American Friends of Dental Volunteers for Israel (AFDVI) is to promote oral health and prevent suffering among children, youth, and the elderly, and to promote volunteerism and cross-cultural understanding. Through fundraising and volunteer recruitment efforts in the United
States, AFDVI supports the work of Dental Volunteers for Israel at the Trudi Birger Dental Clinic, which provides free dental care and oral health education to Jerusalem’s underprivileged and special needs children and at-risk youth regardless of racial, ethnic, or religious background. DVI also provides free preliminary care and dentures to needy elderly, including Holocaust survivors. For more information about American Friends of Dental Volunteers for Israel and the Trudi Birger Dental Clinic please visit us at www.americanfriendsofdvi.org,Facebook.com/AmericanFriendsofDVI, @americanfriendsofdvi on Instagram, and @friendsofdvi on Twitter
Dr. Scott M. Dubowsky, DMD, FAGD, AFDVI President and DVI Clinic volunteer treating a young adult at the clinic.
About Dental Volunteers for Israel and the Trudi Birger Dental Clinic
Since its founding in 1980, Dental Volunteers for Israel has been providing free dental care to Jerusalem's most underprivileged children. At the state-of-the-art Trudi Birger Dental Clinic, children and young adults of all faiths, referred by the Department of Social Welfare and shelters, are treated by dentists from around the world. Volunteering services range from routine to complex dental procedures. DVI also runs a comprehensive preventative dental care program to help young patients develop good, long-term oral health habits. In 2016, DVI expanded to provide free dentures to needy seniors, including Holocaust survivors. This worldwide work is made possible not only by the dentists who come to Israel and donate their time and expertise, but also by businesses and individuals who donate supplies, equipment, and financial resources for DVI’s operating budget.
Although oral care is a key contributor to overall health, it is often considered an unaffordable luxury to underserved people who have little choice but to do without it. DVI treats thousands of children and youth and hundreds of seniors each year at the clinic, yet there are many more who need help.
DVI has won awards from the Mayor of Jerusalem, the Israel Ministry of Health, and the Movement for a Better Israel, which notably lauded DVI for encouraging brotherhood and tolerance between Jews and Arabs.
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company's common stock.
This program is in addition to the $400 million repurchase program announced in December 2018, which as of today has approximately $75 million remaining authorized for future repurchases.
The Company had approximately 147 million shares outstanding as of October 30, 2019. This new authorization represents approximately 4.0 percent of shares outstanding at the current stock price. Purchases may be made from time to time in the open market, or through negotiated transactions.
"Henry Schein's share repurchase program demonstrates our long-term commitment to create additional shareholder value and reflects our confidence in the long-term prospects of our business," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "We are pleased that Henry Schein's solid balance sheet provides us with the financial flexibility to return capital to our shareholders, as we continue to pursue new markets and geographies while strengthening and broadening our health care product and service offerings."
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries. The Company's sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.
Cautionary Note Regarding Forward-Looking Statements
In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate," “to be,” “to make” or other comparable terms. A full discussion of our operations and financial condition, status of litigation matters, including factors that may affect our business and future prospects, is contained in documents we have filed with the United States Securities and Exchange Commission, or SEC, and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.
Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive and consolidating market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; increases in shipping costs for our products or other service issues with our third-party shippers; general global macro-economic conditions; risks associated with currency fluctuations; risks associated with political and economic uncertainty; disruptions in financial markets; volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; new or unanticipated litigation developments and the status of litigation matters; the dependence on our continued product development, technical support and successful marketing in the technology segment; our dependence on third parties for certain technologically advanced components; increased competition by third party online commerce sites; risks from disruption to our information systems; cyberattacks or other privacy or data security breaches; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority.
We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.
Oral Reconstruction Global Symposium
New York City, NY, USA, April 30 – May 2, 2020 – Register now!
Mark your calendar for the Oral Reconstruction Global Symposium 2020 at the iconic New York Marriott Marquis from April 30 to May 2, 2020. Under the theme "20/20 Vision" a world-renowned lineup of speakers promises to cover a wide range of contemporary issues in implant dentistry and tissue regeneration.
The Global Symposium offers a great opportunity to stay abreast of the latest treatment options while enjoying time with colleagues in the heart of Times Square.
Breakout Sessions and Hands-on Exercises
The program will include 16 breakout sessions – held in English, German, Spanish and Chinese – on topics such as digital workflow, immediate full-arch treatment, L-PRF applications, hard and soft tissue grafting, immediate placement and temporization, prevention and management of peri-implant diseases, and many more.
A Three-day Program
The three-days include topics that characterizes what is important for obtaining “20/20 Vision”. Over 40 internationally recognized speakers are presenting the newest developments on topics ranging from extraction site managment to tissue regeneration and long-term sustainability. The symposium will conclude with interactive case presentations discussing solutions for challenging situations.
New York City, New York
New York City (NYC) is the city that never sleeps, and most would agree that there is no city quite like it. Also known as The Big Apple, NYC is one of the most popular tourist destinations in the world, and with good reason. It is the mecca of business in the United States, and as a melting pot of American culture, there is something for every style, taste and budget. Go to www.nycgo.comfor the official guide to New York City.
For more information and to register, visit www.orfoundation.org/globalsymposium.
Attendance will be limited to maintain an environment conducive to learning. Early registration is recommended.
Please follow us on social media via the official hashtag #ORGS2020.
Find us on:
Ballaigues/Charlotte, October 30, 2019. Despite advancements made in oral health throughout the globe, the state of oral health in certain parts of the world remain sub-standard. In many developing countries, access to oral health care is limited and teeth are often left untreated or are extracted because of pain or discomfort.
Organizations like Project Somos, a Canadian based non-profit, work to improve the gap by educating kids and families in the Tecpán area of Guatemala about the importance of nutrition, overall hygiene as well as dental hygiene.
Sponsored by Dentsply Sirona, more than 40 kids, 3 to 8 years old, received dental care during the 2-day dental mission held on September 25 and October 2 at the Maxillofacial Centre in Antigua, Guatemala.
For most, the trip to the dentist would be their first, since they come from impoverished areas where running water or even electricity is scarce.
“These are children who live in homes similar to shelters with dirt floors, so their hygiene isn’t up to the same standards that we are accustomed to,” said Julien Dumont, Global Development Manager at Project Somos.
Guatemala is one of the poorest countries in the Western Hemisphere with high rates of malnutrition and infant mortality.1,2About half of children under five suffer from stunted growth and poor health due to chronic malnutrition, according to the World Food Programme.3
In indigenous communities near Project Somos, preventive dental care is not something most can afford. By the time they go to the dentist, it’s usually too late.
“In our learning village, we give each kid a toothbrush and toothpaste and we have them brush their teeth after every meal – we build this kind of habit so it becomes automatic for them,” said Julien Dumont.
A trip to the dentist
On site were three dentists, Dr. Luis Ramirez, DDS, owner of the Maxillofacial Centre, Dr. Kenneth Pineda, member of the San Carlos University Council in Guatemala City - Faculty of Dentistry, Dr. Ana Lucrecia Arias Ramirez, owner of Odontologia Clinica Integral Dra., and three nurses and an assistant.
All patients received a panoramic X-ray or OPT, and a clinical examination to determine the rate of decayed, missing or filled teeth.
While few needed tooth extractions, dental decay was the most frequent diagnosis – the main reason being lack of oral hygiene, bad eating habits and little to no education, according to Dr. Ramirez. Overall, most of the children were treated for cavities with fillings, some were given fluoride applications, and some received root canal treatments.
“We are pleased to have the opportunity to help support Project Somos and the amazing work they are doing for children and families who desperately need oral care in this part of Guatemala,” said Daniel Nobs, Sr. Clinical Education Manager, Consumables, Dentsply Sirona. “As a company, it is our responsibility to improve access to oral health care and reduce disparities in oral health.”
To help ease any anxiety, while performing the examination, the dentists would tell each child what they were doing and demonstrate how to properly brush their teeth.
“More often than not, because of lack of resources and education, people here go to the dentist when there is no other option than extraction,” said Julien Dumont. “These two days have helped build a new belief around visiting the dentist and reinforced the importance of daily dental hygiene not only for the kids but also for their families and the rest of the community.”
For more information about Project Somos, visit https://projectsomos.org/.
1 Retrieved from UNICEF: https://data.unicef.org/country/gtm/
2 Retrieved from World Bank: https://www.worldbank.org/en/country/guatemala/overview#1
3 Retrieved from World Food Programme: https://www.wfp.org/countries/guatemala
ABOUT DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarter is located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
The 36th Annual American Academy of Cosmetic Dentistry (AACD) Scientific Session in Orlando April 22 – 25, will feature two world-renowned dental professionals, Dr. John C. Kois, and Dr. Iñaki Gamborena. Each year, the Professional Education Committee (PEC) works diligently to program the highest quality education possible and 2020 is no exception. These headlining educational lectures are included in attendees’ all-inclusive tuition package meaning attendees do not have to pay per course. All conference attendees are encouraged to attend these headlining educators’ presentations.
Dr. Kois, the Founder and Director of the Kois Center, received his DMD from the University of Pennsylvania, School of Dental Medicine and his Certificate in Periodontal Prosthodontics with a MSD degree from the University of Washington, School of Dentistry. He currently maintains a private practice limited to Prosthodontics in Tacoma and Seattle and is an Affiliate Professor in the Graduate Restorative Program at the University of Washington.
Dr. Kois will be presenting, “Does Your Dataset Match Your Mindset: Understanding Clinical Failures”, Saturday, April 25, 9:00 am - 4:15 pm. Dr. Kois’ presentation will provide conceptual framework for clinical practice that is simple to implement and will create a paradigm shift in the way attendees interface with their patients and collect data. In addition, the program will introduce new dental software that will link the benefits of evidence-based science to clinical protocols. The results will provide dental professionals with all the necessary analysis to improve quality assurance and seamlessly integrate new, developing technologies.
Dr. Gamborena received his dental degree from Universidad Odontológica Dominicana in 1989. He then pursued his post graduate training in the U.S. with a certificate in Prosthodontics and Master of Science degree in Dentistry from the University of Washington in 1996. Dr. Gamborena is currently an Affiliate Professor at the University of Washington, an assistant professor at the department of preventive and restorative sciences at the University of Pennsylvania, and clinical assistant professor at the department of periodontics at Medical College of Georgia.
Dr. Gamborena will be presenting, “Key Surgical and Prosthetic Considerations to Achieve Optimal Esthetic Outcomes in the Esthetic Area”, Friday, April 24 | 9:00 am - 5:00 pm. This course will have two focuses: the first on the different clinical criteria, sequencing / timing and current surgical-prosthetic techniques for maximizing optimal and predictable aesthetic outcomes in the anterior zone, and the second on how to achieve gingival integration and aesthetic success involving complex aesthetic failures on implants and natural teeth.
The 36th Annual AACD Scientific Session headlining speakers will ultimately open the minds of attendees so they can challenge themselves to be their best and reach their goals.
For more information or to register for the 36th Annual AACD Scientific Session, visit www.aacdconference.com.
About the AACD
The AACD is the world’s largest non-profit member organization dedicated to advancing excellence in comprehensive oral care, combining art and science to optimally improve dental health, esthetics, and function. Comprised of more than 5,000 cosmetic dental professionals in 70 countries worldwide, the AACD fulfills its mission by offering superior educational opportunities, promoting and supporting the respected Accreditation and Fellowship credentials, serving as a user-friendly and inviting forum for the creative exchange of knowledge and ideas, and providing accurate and useful information to the public and the profession.
Dr. Benjamin Kaffenberger examines a patient at The Ohio State University Wexner Medical Center. He led a study that found healthy lifestyle changes, such as practicing good dental hygiene and eating fruit every day, may help improve psoriasis symptoms.
A new study by researchers at The Ohio State University Wexner Medical Center is giving insight into certain lifestyle choices that may prevent or improve psoriasis, helping experts better understand what triggers the disease.
Dental health and diet may have an impact on the development and severity of psoriasis, according to a study by dermatologists at The Ohio State University Wexner Medical Center. Psoriasis is a skin disease that causes thick, itchy patches of red skin with silvery scales and affects more than 8 million Americans.
The study found psoriasis patients who rated their gum health as poor or very poor exhibited significantly more severe psoriasis symptoms than those with healthy gums. Conversely, patients who reported consuming fresh fruit at least once a day experienced milder psoriasis symptoms. The study was published in the Dermatology Online Journal.
“Psoriasis is an autoimmune disease so although it often presents as red, scaly patches on the skin, we know that the causes and consequences are more than skin deep,” said Dr. Benjamin Kaffenberger, a dermatologist at the Ohio State Wexner Medical Center who led the study.
Psoriasis, which can last a lifetime, is caused by a problem with the immune system. In a process called cell turnover, skin cells that grow deep in the skin rise to the surface. Normally this takes a month but with psoriasis, it happens in just a few days because the cells rise too quickly. Treatments include creams, medicines and ultraviolet light therapy.
“We’re looking for some sort of trigger that sets off the immune system. Because strep throat is one of the known triggers and the microbiome of bacteria in the mouth is much more complex, that became our starting point,” said Kaffenberger, who is also an associate professor in Ohio State's College of Medicine. “We wondered if poor dental health could be a risk factor for psoriasis.”
Researchers created a specially designed lifestyle and diet questionnaire that was administered to 265 patients at Ohio State’s dermatology clinics. The study surveyed 100 patients with psoriasis and 165 without the disease. The study showed poor dental and oral health, in particular gum pain, was associated with those who had psoriasis.
“Patients who had more severe psoriasis were more likely to report that their gums were in worse condition than patients who didn’t have mild to moderate psoriasis in the first place,” Kaffenberger said. “And patients who had higher fruit consumption reported less significant psoriasis, indicating fruit and potentially fresh foods may be an associated protective factor.”
The study also reinforced data from previous studies that found family history of psoriasis, smoking and obesity were significant predictors of psoriasis.
Kaffenberger hopes to expand the study outside Ohio State’s dermatology clinics and survey thousands of psoriasis patients with varying degrees of the disease. While Kaffenberger noted that the study’s results were very preliminary, he believes having dermatologists screen for dental health and counsel psoriasis patients for improved dietary health may help them.
“Psoriasis is a chronic disease and can be so severe that it covers the entire body. Patients ask us ‘If I change my diet, will I get rid of this disease?’ That’s what really drove the onset of this study – to see what health and lifestyle changes patients could make,” Kaffenberger said. “The key is to protect your gums and your mouth by brushing your teeth twice a day and flossing. Lifestyle changes include quitting smoking, avoiding high alcohol consumption and properly managing diabetes.”
The American College of Prosthodontists' 2019 Annual Session will be in Miami Beach Oct. 30-Nov. 2
The 2019 Annual Session of the American College of Prosthodontists (ACP) is taking place in Miami from Oct. 30 to Nov. 2. The premier prosthodontic meeting of the year will draw more than 1,000 specialists in prosthetic dentistry and advanced dental technology, including educators, private practitioners, and industry leaders.
"We are very excited to host our meeting in the bright and vibrant city of Miami," said ACP President Nadim Z. Baba, DMD, MSD, FACP. "To be in a city so full of life, while focusing on the advancements that improve people's lives through prosthodontics, makes Miami a perfect fit for the ACP's 49th Annual Session."
Led by scientific program chair Carlo Ercoli, DDS, MBA, FACP, and ACP President Dr. Nadim Z. Baba, this year's Annual Session is focused on the forces that are driving the prosthodontic specialty forward. Speakers will describe how advances in technology and biology are allowing practitioners to avoid complications, achieve superior esthetics, and ultimately improve patient care.
"A lineup of world-class speakers will detail the latest evidence on ceramic restorations, diagnosis with advanced digital imaging, and state-of-the-art digital workflows," said Dr. Ercoli. "In complex cases where biology, technology, and evidence-based treatment planning come together, prosthodontists are the specialists at the center of patient care."
A prosthodontist is a dental specialist focused on the restoration and replacement of missing or damaged teeth, and other oral or facial issues. They work to restore optimum appearance and function to your smile through treatments like implants, dentures and veneers, all the way to full mouth and jaw reconstructions.
To learn more about the event, and the dental specialists attending, visit ACP49.com.
About the ACP
The American College of Prosthodontists (ACP) is the association that represents the specialty of prosthodontics. Founded in 1970, the ACP is dedicated to advancing the art and science of prosthodontics and promoting the specialty to the public and dental professionals. For more information, consumers can visit GoToAPro.org and dental professionals can visit Prosthodontics.org.
The small, swift and clever Planmeca Compact™ i3 dental care unit is a smart choice for any dentist looking for a space-saving and functional solution. Combining great ergonomics, a smooth workflow and ease of use, this truly flexible unit allows both right and left-handed dental professionals to work comfortably in any position.
Planmeca Compact™ i is Planmeca’s most widely sold dental unit range with over 50,000 deliveries to dental clinics around the world. The tried, tested and proven product line is now growing with a new swift and small member to meet the needs of all dental professionals, but especially those of large clinics and dental chains.
The flexible movement range of the unit’s delivery arm brings both ergonomic and space-saving benefits to dental clinics. Planmeca Compact i3 can be switched from right to left-hand use in just 10 seconds simply by moving the instrument console − without having to move the operating light. This makes it a practical solution for all clinics where several dentists use the same dental unit and space is limited.
Due to its slim design, Planmeca Compact i3 fits into any clinic layout. With plenty of working space around it, the unit allows the dental team to work comfortably whether sitting or standing. The small instrument console can be positioned above the patient, making it easier to maintain an ergonomic position throughout the day. The unit’s swivel function can be used to make further fine adjustments according to one’s preferences. The unit is suited for both two and four-handed working techniques.
Designed to simplify everyday dentistry, Planmeca Compact i3 is both easy to learn and easy to use. The intuitive touch panel guides the user in their preferred language, and the simplicity of the unit’s design makes external infection control procedures easy and straightforward to perform. The unit can also be customised to individual preferences and upgraded with the features of one’s choice, such as an integrated intraoral scanner.
To fit the needs of large clinics, the one-of-a-kind Planmeca PlanID™ sign-in system allows dentists to access their personal settings instantly from any dental unit with a simple flash of a card. This helps clinics utilise their equipment flexibly, since dental units no longer need to be assigned to specific users. All usage information is stored in the Planmeca Romexis® software – this way, large clinics and chains can benefit from knowing when, how and by whom the unit has been used.
“We believe that great ergonomics, ease of use and a smooth workflow should be necessity, not a luxury. Just like all our dental unit models, the new Planmeca Compact i3 offers all these advantages and more,” says Jukka Kanerva, Vice President for Planmeca’s Dental Care Units & CAD/CAM division.
Planmeca Oy and Planmeca Group
Planmeca Oy is one of the world's leading dental equipment manufacturers with a product range covering digital dental units, CAD/CAM solutions, world-class 2D and 3D imaging devices and comprehensive software solutions. Headquartered in Helsinki, Finland, Planmeca’s products are distributed in over 120 countries worldwide. With a strong commitment to pioneering innovations and design, it is the largest privately held company in its field. Planmeca Oy is part of the Finnish Planmeca Group, which operates in the field of healthcare technology. The Group's turnover in 2018 was MEUR 746, and it employs nearly 2,800 people worldwide.
The American Dental Association (ADA) announced today a new guideline indicating that in most cases, antibiotics are not recommended for toothaches. This guidance, published in the November issue of the Journal of the American Dental Association, aligns with the ADA’s longstanding antibiotic stewardship efforts and its pledged commitment to the U.S. government’s Antimicrobial Resistance Challenge.
Patients with toothaches are often prescribed antibiotics by physicians and dentists to help relieve signs and symptoms and prevent progression to a more serious condition. However, the new guideline and accompanying systematic review find that healthy adults experiencing a toothache are best served not by antibiotics but by dental treatment and, if needed, over-the-counter pain relievers such as acetaminophen and ibuprofen.
“Antibiotics are, of course, tremendously important medications,” said Peter Lockhart, D.D.S., chair of the ADA expert panel that developed the guideline and research professor at Carolinas Medical Center - Atrium Health. “However, it’s vital that we use them wisely so that they continue to be effective when absolutely needed.”
Studies have shown that antibiotics, which are designed to stop or slow the growth of bacterial infections, don’t necessarily help patients experiencing a toothache. In addition, antibiotics can cause serious side effects, and overuse has resulted in bacterial strains that are resistant to antibiotics.
The guideline offers example scenarios when antibiotics may be prescribed for a toothache. “When dental treatment is not immediately available and the patient has signs and symptoms such as fever, swollen lymph nodes, or extreme tiredness, antibiotics may need to be prescribed,” said Dr. Lockhart. “But in most cases when adults have a toothache and access to dental treatment, antibiotics may actually do more harm than good.”
About the ADA
The not-for-profit ADA is the nation's largest dental association, representing 163,000 dentist members. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance long has been a valuable and respected guide to consumer dental care products. The monthly The Journal of the American Dental Association (JADA) is the ADA's flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit ADA.org. For more information on oral health, including prevention, care and treatment of dental disease, visit the ADA's consumer website MouthHealthy.org.
First-of-Its-Kind, Ground-Breaking Landmark Clinical Studies
Paradigm-Shifting Research from IMC The McGuire Institute
By Clinical Investigators: Michael McGuire, DDS; Don Clem, DDS; Todd Scheyer, DDS, MS; Rick Heard, DDS, MS; Chris Richardson, DMD, MS; and Greg Toback, DMD, MS
DISCUSSION EXCLUSIVELY AT THIS AAP 2019 CORPORATE FORUM:
Innovative Management of Periodontal and Implant Conditions with ER,Cr:YSGG Laser Technology
A prospective, multicenter, randomized, blinded and controlled study comparing REPaiR™ and MIST Therapies for Treatment of Moderate to Severe Generalized Periodontitis.
Analysis of Er,Cr:YSGG laser in managing severe periodontal disease using clinical and radiographic parameters along with patient reported outcomes.
Rick Heard, DDS, MS
Executive Director of Clinical Research and Operations,iMc The McGuire Institute
Er,Cr:YSGG Laser’s Role in Treating Peri-implantitis: A Clinical Case Series.
Histological, Histomorphometric and Radiographic Analysis of Utilizing the Erbium laser's ability to manage peri-implantitis by decontaminating implants and induction of re-osteointegration.
Ron Nevins, DDS
Editor of the International Journal of Periodontics & Restorative Dentistry and Associate Clinical Professor of Periodontology at the Harvard School of Dental Medicine
Corporate Forum Moderated by
Samuel B. Low, DDS, MS, M.Ed
Saturday, November 2, 2019 • 4:00PM - 4:45PM
McCormick Place, Chicago, IL, South Building, Level 4, East Concourse - 404D